GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GSK GlaxoSmithKline PLC

Trading 04-26 12:01:31 EDT

41.19

+0.28

+0.68%

High41.23	Low40.87	Vol967.01K
Open40.91	D1 Closing40.91	Amplitude0.87%
Mkt Cap84.15B	Tradable Cap81.12B	Total Shares2.04B
T/O39.74M	T/O Rate0.05%	Tradable Shares1.97B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"GlaxoSmithKline PLC","latestPrice":41.1895,"timestamp":1714147278926,"preClose":40.91,"halted":0,"volume":967008,"delay":0,"floatShares":1969491234,"shares":2043031374,"eps":3.054466,"marketStatus":"Trading","change":0.2795,"latestTime":"04-26 12:01:31 EDT","open":40.91,"high":41.225,"low":40.87,"amount":39741127.776,"amplitude":0.008678,"askPrice":41.19,"askSize":116,"bidPrice":41.18,"bidSize":300,"shortable":3,"etf":0,"ttmEps":3.054466,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1714161600000},"marketStatusCode":2,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":40.91,"dividendRate":0.035233,"preHourTrading":{"tag":"盘前","latestPrice":40.94,"preClose":40.91,"latestTime":"09:29 EDT","volume":4702,"amount":192514.47500799998,"timestamp":1714138199999},"postHourTrading":{"tag":"盘后","latestPrice":40.91,"preClose":40.91,"latestTime":"19:53 EDT","volume":454991,"amount":18613678.57,"timestamp":1714089217848},"volumeRatio":0.954817},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2430509692","title":"These Are The Biotechs Showing Up At The Biggest Cancer Meeting Of The Year (Oral Presentations)","url":"https://stock-news.laohu8.com/highlight/detail?id=2430509692","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2430509692?lang=en_us&edition=fundamental","pubTime":"2024-04-26 05:49","pubTimestamp":1714081756,"startTime":"0","endTime":"0","summary":"The Annual Meeting of the American Society of Clinical Oncology is a major event for clinicians and researchers in the field of oncology.The plenary session will feature presentations on topics such a","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1482998631/image_1482998631.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1482998631/image_1482998631.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4686392-these-are-the-biotechs-showing-up-at-the-biggest-cancer-meeting-of-the-year-oral-presentations","is_publish_highlight":false,"gpt_icon":0},{"id":"2430723585","title":"BUZZ-Pfizer, BioNTech fall as GSK sues over COVID-19 vaccine technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2430723585","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2430723585?lang=en_us&edition=fundamental","pubTime":"2024-04-25 23:50","pubTimestamp":1714060204,"startTime":"0","endTime":"0","summary":"** Shares of vaccine makers Pfizer    and BioNTech  fall between 2% to 3%   ** Drugmaker GlaxoSmithKline    sues BNTX and PFE accusing them of infringing its patents related to messenger RNA  technology in the companies' blockbuster COVID-19 vaccines   ** GSK says that PFE and BNTX's Comirnaty vaccines violate its patent rights in mRNA-vaccine innovations developed \"more than a decade before\" the outbreak of the COVID-19 pandemic   ** GSK also asked the Delaware federal court for an unspecified amount of monetary damages from both companies that includes an ongoing patent-licensing fee   ** A Pfizer spokesperson said in a statement that the company is \"confident in our IP position around Comirnaty\" and intends to \"vigorously defend\" against GSK's claims, while a BioNTech spokesperson declined to comment    ** Including session moves, PFE down 11.3% and BNTX down 18.1% YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430233950","title":"20 Fastest Growing Health Tech Companies in the World","url":"https://stock-news.laohu8.com/highlight/detail?id=2430233950","media":"Insider Monkey","top":-1,"share":"https://ttm.financial/m/news/2430233950?lang=en_us&edition=fundamental","pubTime":"2024-04-25 23:34","pubTimestamp":1714059264,"startTime":"0","endTime":"0","summary":"In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World.Explosive Growth and Key Trends in the Digital Health Market. The digital health market has been striding and was valued at $180.2 billion in2023with an expectation to grow to $549.7 billion by 2028, growing at a CAGR of 25% between 2024-2028. The digital health industry consists of a wide range of technologies that include mHealth  devices and apps, telehealth, digital therapeutics, and healthcare management systems. The key players in the digital health industry include DexCom, Biotricity, iHealth Labs, and AirStrip Technologies, among others.Precision medicine has been widely transforming healthcare by leveraging advanced technologies, and data analytics which helps personalizing medical interventions based on an individual’s unique prefe","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/O5WXIJrlF3Qf6muJllUq4g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8e984c21a437e828274169c9f37cff34","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/O5WXIJrlF3Qf6muJllUq4g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8e984c21a437e828274169c9f37cff34"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/20-fastest-growing-health-tech-153424027.html","is_publish_highlight":false,"gpt_icon":1},{"id":"2430285672","title":"GlaxoSmithKline Sues Pfizer and BioNTech Over Covid-19 Vaccine Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2430285672","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2430285672?lang=en_us&edition=fundamental","pubTime":"2024-04-25 23:10","pubTimestamp":1714057800,"startTime":"0","endTime":"0","summary":"April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":true,"gpt_icon":1},{"id":"2430499015","title":"Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks","url":"https://stock-news.laohu8.com/highlight/detail?id=2430499015","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2430499015?lang=en_us&edition=fundamental","pubTime":"2024-04-25 03:51","pubTimestamp":1713988260,"startTime":"0","endTime":"0","summary":"Wednesday, April 24, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Danaher Corp","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kwmQZSYpmN.EY.GVMCVRlg--~B/aD0zNjU7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/50cc92fda67def26e4faa87a843224e5","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kwmQZSYpmN.EY.GVMCVRlg--~B/aD0zNjU7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/50cc92fda67def26e4faa87a843224e5"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/top-stock-reports-danaher-regeneron-195100837.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430469650","title":"Madrigal: 2 Challenges To Overcome To Maintain NASH 'First Mover' Advantage","url":"https://stock-news.laohu8.com/highlight/detail?id=2430469650","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2430469650?lang=en_us&edition=fundamental","pubTime":"2024-04-25 01:02","pubTimestamp":1713978150,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals, Inc. recently received FDA approval for its lead candidate resmetirom, targeting a liver condition called NASH.The NASH market is projected to reach $50 billion by 2035, maki","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1483000268/image_1483000268.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1483000268/image_1483000268.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4685718-madrigal-2-challenges-to-overcome-to-maintain-nash-first-mover-advantage","is_publish_highlight":false,"gpt_icon":0},{"id":"2430957465","title":"GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2430957465","media":"Zacks","top":-1,"share":"https://ttm.financial/m/news/2430957465?lang=en_us&edition=fundamental","pubTime":"2024-04-24 22:01","pubTimestamp":1713967291,"startTime":"0","endTime":"0","summary":"Wall Street expects a year-over-year increase in earnings on higher revenues when GSK  reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 1. On the other hand, if they miss, the stock may move lower.While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.This drug developer is expected to post quarterly earnings of $0.94 per share in its upcoming report, which represents a year-over-year change of +4.4%.Please note that a negative Earnings ESP reading is ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/e0VWXB5.wUFiKGuJPPpLzg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/a7cdcede0bb5a646be035f4a7e678781"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gsk-gsk-earnings-expected-grow-140131545.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429523437","title":"GSK’s Jemperli Awaits FDA Expansion Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2429523437","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2429523437?lang=en_us&edition=fundamental","pubTime":"2024-04-24 19:57","pubTimestamp":1713959871,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline (GSK) has announced that the US FDA has granted priority review for the expansion of ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-awaits-fda-expansion-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-jemperli-awaits-fda-expansion-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2429434195","title":"CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK","url":"https://stock-news.laohu8.com/highlight/detail?id=2429434195","media":"ACCESSWIRE","top":-1,"share":"https://ttm.financial/m/news/2429434195?lang=en_us&edition=fundamental","pubTime":"2024-04-24 19:20","pubTimestamp":1713957600,"startTime":"0","endTime":"0","summary":"Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza  virus, considered to be potential future pandemic threat. Study will assess monovalent vaccine candidate, encoding an influenza A H5-antigen using proprietary second-generation mRNA backbone. CureVac  is a global biopharmaceutical company in the field of messenger RNA  technology, with more than 20 years of expertise in developing, optimizing, and manufacturing this versatile biological molecule for medical purposes. The principle of CureVac's proprietary technology is the use of optimized mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases. In July 2020, CureVac enter","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PewipmVKVUrnbqRXNzUG_A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/a441730f7f4e8dc0ab9bcf6fbdca6438","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PewipmVKVUrnbqRXNzUG_A--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/a441730f7f4e8dc0ab9bcf6fbdca6438"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/curevac-announces-start-combined-phase-112000749.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429439075","title":"Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2429439075","media":"Business Wire","top":-1,"share":"https://ttm.financial/m/news/2429439075?lang=en_us&edition=fundamental","pubTime":"2024-04-24 19:00","pubTimestamp":1713956400,"startTime":"0","endTime":"0","summary":"Single-dose, oral zoliflodacin achieved 90.9% microbiological cure rate, demonstrating statistical non-inferiority compared to current global standard of care. Pivotal Phase 3 data to be presented by the Global Antibiotic Research & Development Partnership  in a Scientific Sessions Oral Presentation. First collaborative study between industry and a non-profit to address a World Health Organization high priority pathogen and U.S. Centers for Disease Control urgent threat. \"Presenting these findings to the scientific community for the first time is a significant milestone in the journey of this important antibiotic in the fight against Neisseria gonorrhoeae, a World Health Organization priority pathogen,\" said Dr. Alison Luckey, Senior Medical Lead for GARDP’s Sexually Transmitted Infections programme. \"These positive findings not only represent a step forward in the treatment of gonorrhoea if approved, but also demonstrate the pivotal role that this public-private partnership between GA","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Z7hwAW9a.r6CwugBf7HT8g--~B/aD05Mzg7dz04NjE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cc36e8b95dd8bfacbd206e06afc80460","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Z7hwAW9a.r6CwugBf7HT8g--~B/aD05Mzg7dz04NjE3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/cc36e8b95dd8bfacbd206e06afc80460"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/innoviva-specialty-therapeutics-positive-phase-110000772.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429431501","title":"US regulator accepts GSK’s application to expand treatment of cancer drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2429431501","media":"cityam","top":-1,"share":"https://ttm.financial/m/news/2429431501?lang=en_us&edition=fundamental","pubTime":"2024-04-24 18:07","pubTimestamp":1713953264,"startTime":"0","endTime":"0","summary":"GSK’s application to expand the treatment was supported by “statistically significant” and “clinically meaningful” data from clinical trials.Jemperli plus chemotherapy has been shown to be the only immuno-oncology-based therapy to show such a significant survival benefit in endometrial cancer, GSK said.Endometrial cancer is the most common gynaecologic cancer in developed countries, with approximately 417,000 new cases reported each year worldwide,according to research.Rates are expected to rise by almost 40% between 2020 and 2040,according to the International Agency for Research on Cancer.GSK has only recently moved into the oncology space. Itis “seeking to make transformative breakthroughs in immuno-oncology, focusing on “haematologic malignancies, gynaecologic cancers and other solid tumours through breakthroughs in immuno-oncology and tumour-cell targeting therapies.”","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2024/04/1198805324-1.webp?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2024/04/1198805324-1.webp?w=286&h=161&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.cityam.com/us-regulator-accepts-gsks-application-to-expand-treatment-of-cancer-drug/","is_publish_highlight":false,"gpt_icon":0},{"id":"2429002411","title":"GSK’s Cancer Drug Nears Broader FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2429002411","media":"TIPRANKS","top":-1,"share":"https://ttm.financial/m/news/2429002411?lang=en_us&edition=fundamental","pubTime":"2024-04-24 15:09","pubTimestamp":1713942546,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline plc (UK) (GB:GSK) has released an update. GlaxoSmithKline plc has announced that the US FDA has granted a priority review for the e...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsks-cancer-drug-nears-broader-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsks-cancer-drug-nears-broader-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"gpt_icon":0},{"id":"2429482181","title":"Sanofi reportedly lining up banks for consumer products spinoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2429482181","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429482181?lang=en_us&edition=fundamental","pubTime":"2024-04-24 01:32","pubTimestamp":1713893533,"startTime":"0","endTime":"0","summary":"Sanofi (NASDAQ:SNY) is reportedly lining up banks for a potential spinoff of its consumer health products division. The French drugmaker has asked banks to submit proposals to work on the deal, which ","market":"nz","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1125144281/image_1125144281.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4092701-sanofi-reportedly-lining-up-banks-for-consumer-products-spinoff","is_publish_highlight":false,"gpt_icon":0},{"id":"2429111214","title":"Spero Therapeutics Delivers On Game Plan To Create Shareholder Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2429111214","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429111214?lang=en_us&edition=fundamental","pubTime":"2024-04-23 23:37","pubTimestamp":1713886637,"startTime":"0","endTime":"0","summary":"Spero Therapeutics, Inc. has continued to build and advance its pipeline over the past several months and is now on the verge of generating landmark data with multi-bagger potential.Spero has excellen","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413265641/image_1413265641.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1413265641/image_1413265641.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4685311-spero-therapeutics-delivers-on-game-plan-to-create-shareholder-value","is_publish_highlight":false,"gpt_icon":0},{"id":"2429113418","title":"Takeda Pharmaceutical: A Long-Term Cash Cow","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113418","media":"GuruFocus.com","top":-1,"share":"https://ttm.financial/m/news/2429113418?lang=en_us&edition=fundamental","pubTime":"2024-04-23 22:00","pubTimestamp":1713880803,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co. Ltd.  is the largest Japanese pharmaceutical company and holds a leading position in the global immunoglobulins market.In recent months, the company's share price has continued to be in a downward trend due to two key factors. The first is growing concerns among institutional investors about the impact of generic versions of Vyvanse on the pace of recovery in Takeda's operating income margin. The second factor is President Biden's Inflation Reduction Act's negative impact on the pharmaceutical industry, as it aims to tighten regulation of prescription drug pricing, which could ultimately slow down the introduction of next-generation medicines to the market.However, we believe financial market participants significantly overestimate the impact of these two risks on Takeda's financial position. Moreover, thanks to the steps taken by the company's CEO to optimize administrative and general expenses, label expansions for Adcetris and Takhzyro, as well as the growt","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qvTzIBTFSNnEYDlT_q6_gA--~B/aD0zNDM7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/bc39b7acb8412bbc18d47e9fff4b4c6c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qvTzIBTFSNnEYDlT_q6_gA--~B/aD0zNDM7dz03MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/bc39b7acb8412bbc18d47e9fff4b4c6c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-pharmaceutical-long-term-cash-140003899.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429997221","title":"Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing","url":"https://stock-news.laohu8.com/highlight/detail?id=2429997221","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2429997221?lang=en_us&edition=fundamental","pubTime":"2024-04-23 12:30","pubTimestamp":1713846600,"startTime":"0","endTime":"0","summary":"GSK has selected the first two programs to advance following achievement of target validation, marking transition to next phase of research collaboration; programs utilize Wave’s next generation GalNA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/23/2867671/0/en/Wave-Life-Sciences-Announces-Continued-Momentum-in-GSK-Collaboration-and-Advancements-in-siRNA-and-RNA-Editing.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429979536","title":"SCHY: How The Fed's Policies Make International Dividend Stocks An Attractive Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=2429979536","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429979536?lang=en_us&edition=fundamental","pubTime":"2024-04-23 00:26","pubTimestamp":1713803189,"startTime":"0","endTime":"0","summary":"The US Federal Reserve is expected to maintain higher interest rates while other major central banks, such as the ECB and BoE, are likely to shift to lower interest rates.The divergence in interest ra","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1692418614/image_1692418614.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1692418614/image_1692418614.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4685095-schy-how-fed-policies-make-international-dividend-stocks-an-attractive-bet","is_publish_highlight":false,"gpt_icon":0},{"id":"2429752229","title":"Sanofi reportedly settles 4K Zantac cases for $100M","url":"https://stock-news.laohu8.com/highlight/detail?id=2429752229","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2429752229?lang=en_us&edition=fundamental","pubTime":"2024-04-23 00:03","pubTimestamp":1713801826,"startTime":"0","endTime":"0","summary":"Sanofi (NASDAQ:SNY) has reportedly agreed to pay over $100M to settle around 4,000 cases filed over the safety of its heartburn drug Zantac. Under the settlement, Sanofi will pay around $25,000 per cl","market":"fut","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458584047/image_458584047.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/458584047/image_458584047.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4092016-sanofi-reportedly-settles-4k-zantac-cases-for-100m","is_publish_highlight":false,"gpt_icon":0},{"id":"2428694687","title":"Hepion ends Phase 2 study for NASH drug due to cash restraints","url":"https://stock-news.laohu8.com/highlight/detail?id=2428694687","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428694687?lang=en_us&edition=fundamental","pubTime":"2024-04-20 05:10","pubTimestamp":1713561014,"startTime":"0","endTime":"0","summary":"Hepion Pharmaceuticals (NASDAQ:HEPA) said it has begun winding down its ASCEND-NASH Phase 2 study for its drug rencofilstat as it continues to explore strategic alternatives for the company. “We are d","market":"hk","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/961746674/image_961746674.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/961746674/image_961746674.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4091671-hepion-ends-phase-2-study-for-nash-drug-due-to-cash-restraints","is_publish_highlight":false,"gpt_icon":0},{"id":"2428769685","title":"SpringWorks Therapeutics: Multiple Opportunities, But No Sure-Fire Winners","url":"https://stock-news.laohu8.com/highlight/detail?id=2428769685","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2428769685?lang=en_us&edition=fundamental","pubTime":"2024-04-20 03:55","pubTimestamp":1713556500,"startTime":"0","endTime":"0","summary":"SpringWorks Therapeutics received FDA approval for its oral gamma secretase inhibitor Ogsiveo for the treatment of desmoid tumors in November last year.Ogsiveo is the first therapy approved for desmoi","market":"sh","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1251099248/image_1251099248.jpg","type":0,"news_type":0,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1251099248/image_1251099248.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/article/4684794-springworks-therapeutics-multiple-opportunities-but-no-sure-fire-winners","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0418},{"period":"1month","weight":-0.0439},{"period":"3month","weight":0.0471},{"period":"6month","weight":0.1837},{"period":"1year","weight":0.1386},{"period":"ytd","weight":0.1039}],"compareEarnings":[{"period":"1week","weight":0.0079},{"period":"1month","weight":-0.0295},{"period":"3month","weight":0.033},{"period":"6month","weight":0.226},{"period":"1year","weight":0.2452},{"period":"ytd","weight":0.0593}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.568182,"avgChangeRate":0.012276},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.003512},{"month":3,"riseRate":0.613636,"avgChangeRate":0.0208},{"month":4,"riseRate":0.666667,"avgChangeRate":0.032446},{"month":5,"riseRate":0.386364,"avgChangeRate":-0.010964},{"month":6,"riseRate":0.613636,"avgChangeRate":0.014726},{"month":7,"riseRate":0.545455,"avgChangeRate":0.004705},{"month":8,"riseRate":0.568182,"avgChangeRate":0.001515},{"month":9,"riseRate":0.522727,"avgChangeRate":0.005813},{"month":10,"riseRate":0.522727,"avgChangeRate":0.013998},{"month":11,"riseRate":0.477273,"avgChangeRate":0.011509},{"month":12,"riseRate":0.613636,"avgChangeRate":0.014479}],"exchange":"NYSE","name":"GlaxoSmithKline PLC","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GlaxoSmithKline PLC,GSK,GlaxoSmithKline PLC股票,GlaxoSmithKline PLC股票老虎,GlaxoSmithKline PLC股票老虎国际,GlaxoSmithKline PLC行情,GlaxoSmithKline PLC股票行情,GlaxoSmithKline PLC股价,GlaxoSmithKline PLC股市,GlaxoSmithKline PLC股票价格,GlaxoSmithKline PLC股票交易,GlaxoSmithKline PLC股票购买,GlaxoSmithKline PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GlaxoSmithKline PLC(GSK),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GlaxoSmithKline PLC(GSK) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction